SARASOTA, Fla.--(BUSINESS WIRE)-- Oragenics (OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today announced a ...
Collaboration uses Receptor AI's platform to design highly selective anti-cancer kinase inhibitor products for BriaPro, a BriaCell subsidiary Partnership expected to expand BriaPro's small-molecule ...
Powered by JSON-native architecture and trained on licensed, multi-domain data, FIBO delivers fully controllable, predictable, and brand-safe visual AI, unlocking the next generation of scalable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results